StreetInsider.com News Articles

Form 6-K Burning Rock Biotech For: Mar 12

Fri, 13 Mar 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260313/26155976.html

Form 6-K Burning Rock Biotech For: Mar 12

Fri, 13 Mar 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260313/26155976.html

Burning Rock Biotech Limited (BNR) Misses Q4 EPS by 2c

Fri, 13 Mar 2026 02:28:35 -0400

Burning Rock Biotech Limited (NASDAQ: BNR) reported Q4 EPS of ($0.02). Revenue for the quarter came in at $18.06 million.

For earnings history and earnings-related data on Burning Rock Biotech Limited (BNR) click here.

Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results

Thu, 12 Mar 2026 07:08:00 -0400

GUANGZHOU, China, March 12, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next-generation sequencing (NGS) technology in the field of precision oncology, today reported unaudited financial results for the three months and the year ended December 31, 2025.

2025 Business Overview and Recent Updates

Early Detection
- The core patent related to Burning Rock's proprietary ultrasensitive detection technology,

Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results

Thu, 12 Mar 2026 07:08:00 -0400

2025 Business Overview and Recent Updates

Early Detection
- The core patent related to Burning Rock's proprietary ultrasensitive detection technology,

Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results

Thu, 12 Mar 2026 07:08:00 -0400

2025 Business Overview and Recent Updates

Early Detection
- The core patent related to Burning Rock's proprietary ultrasensitive detection technology,

Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results

Thu, 12 Mar 2026 07:08:00 -0400

2025 Business Overview and Recent Updates

Early Detection
- The core patent related to Burning Rock's proprietary ultrasensitive detection technology,

Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results

Thu, 12 Mar 2026 07:08:00 -0400

2025 Business Overview and Recent Updates

Early Detection
- The core patent related to Burning Rock's proprietary ultrasensitive detection technology,

Burning Rock Reports Unaudited Fourth Quarter and Full Year 2025 Financial Results

Thu, 12 Mar 2026 07:08:00 -0400

2025 Business Overview and Recent Updates

Early Detection
- The core patent related to Burning Rock's proprietary ultrasensitive detection technology,

Burning Rock founder purchases $811,721 in company shares

Mon, 05 Jan 2026 05:47:19 -0400

Burning Rock Biotech Limited (NASDAQ: BNR) announced that founder and chief executive officer Yusheng Han purchased $811,721.28 worth of the company's American depositary shares from the open market.

The transaction was conducted in compliance with applicable regulations and the company's insider trading policy, according to a press release statement. Han serves as chairman of the board of directors and chief executive officer of the precision oncology company.

The company stated that Han may continue purchasing shares through open-market transactions, privately negotiated transactions, block trades, or other legally permissible means. Future purchases will depend on market conditions and compliance with securities regulations, including

Burning Rock founder purchases $811,721 in company shares

Mon, 05 Jan 2026 05:47:19 -0400

Burning Rock Biotech Limited (NASDAQ: BNR) announced that founder and chief executive officer Yusheng Han purchased $811,721.28 worth of the company's American depositary shares from the open market.

Burning Rock Announces Founder’s Purchase of Its ADSs

Mon, 05 Jan 2026 01:16:20 -0400

GUANGZHOU, China, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focusing on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that as of the date of this press release, its founder, chairman of the board of directors and chief executive officer, Mr. Yusheng Han, has purchased US$811,721.28 of the Company’s ADSs from the open market, which was conducted in compliance with the applicable rules and regulations and the Company’s insider trading policy. Mr. Han’s purchase of the Company’s ADSs

Burning Rock Announces Founder’s Purchase of Its ADSs

Mon, 05 Jan 2026 01:16:20 -0400

Form 6-K Burning Rock Biotech For: Dec 23

Tue, 23 Dec 2025 06:11:00 -0400

si-local-file:///var/storage/secattach/20251223/25772827.html

Form 6-K Burning Rock Biotech For: Dec 23

Tue, 23 Dec 2025 06:11:00 -0400

si-local-file:///var/storage/secattach/20251223/25772827.html

Burning Rock Announces Results of 2025 Annual General Meeting